Rise Therapeutics Llc

This early-stage study is testing a new oral probiotic called R-2487 in people with Sjogren's Syndrome, an autoimmune disease. The main goal is to see if the probiotic is safe and well-tolerated. Researchers will also check if it helps reduce disease activity and improves patient…

This early-stage study is testing the safety of an oral probiotic called R-3750 in people with mild to moderate COPD. The 27 participants will take the probiotic and report on their symptoms and quality of life. Researchers will also check blood and stool samples to see if the pr…